Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03041701
Brief Title: Insulin-like Growth Factor 1 Receptor (IGF-1R) Antibody AMG479 (Ganitumab) in Combination With the Src Family Kinase (SFK) Inhibitor Dasatinib in People With Embryonal and Alveolar Rhabdomyosarcoma

First Submitted : February 2, 2017
First Submitted that Met QC Criteria : February 2, 2017
First Posted : February 3, 2017 (Estimate)

Last Update Submitted that Met QC Criteria : September 15, 2021
Last Update Posted : September 16, 2021